tiprankstipranks
Trending News
More News >
Statera BioPharma (STAB)
OTHER OTC:STAB
US Market

Statera BioPharma (STAB) Income Statement

Compare
190 Followers

Statera BioPharma Income Statement

Last quarter (Q3 2022), Statera BioPharma's total revenue was $670.47K, an increase of 183.48% from the same quarter last year. In Q3, Statera BioPharma's net income was $-5.16M. See Statera BioPharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -488.31K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 28.83M$ 10.50M$ 2.81M$ 5.94M$ 7.55M
Depreciation and Amortization
$ 255.57K$ 947.00$ 13.78K$ 18.18K$ 21.08K
EBITDA
$ 38.93M$ -2.59M$ -2.36M$ -4.80M$ -5.60M
Operating Income
$ -98.34M$ -10.50M$ -2.81M$ -4.80M$ -5.60M
Other Income/Expenses
$ -3.53M$ -1.59M$ -409.85K$ 1.19M$ -4.11M
Pretax Income
$ -101.88M$ -12.09M$ -3.22M$ -3.61M$ -9.71M
Net Income
$ -174.41M$ -13.22M$ -3.35M$ -3.61M$ -9.71M
Per Share Metrics
Basic EPS
$ -4.97$ -0.52$ -0.13$ -0.32$ -0.87
Diluted EPS
$ -4.97$ -0.52$ -0.13$ -0.32$ -0.87
Weighted Average Shares Outstanding
35.11M 25.65M 25.65M 11.29M 11.19M
Weighted Average Shares Outstanding (Diluted)
35.11M 25.65M 25.65M 11.29M 11.19M
Currency in USD

Statera BioPharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis